Parthenolide

DB13063ApprovedInvestigationalSmall moleculeStandardized Chemical Allergen

Parthenolide has been used in trials studying the diagnostic of Allergic Contact Dermatitis.

Chemical structure of Parthenolide
Formula / weight
C15H20O3 · 248.3175 g/mol (avg)
First approval
United States, 2012

Resolves to

Compound
UNII2RDB26I5ZBCAS20554-84-1ChEMBLCHEMBL540445PubChem6473881KEGGC07609
Clinical / RWD
RxNorm32941
Structure
InChIKeyKTEXNACQROZXEV-SLXBATTESA-NSMILESC\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1
Targets
Q04864RELQ01201RELBQ04206RELAQ00653NFKB2P19838NFKB1O14920IKBKB

What you can answer from here — as of May 21, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Parthenolide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In